Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Receivables (2016 - 2025)

Historic Receivables for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to $215.9 million.

  • Phibro Animal Health's Receivables rose 1255.7% to $215.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $215.9 million, marking a year-over-year increase of 1255.7%. This contributed to the annual value of $228.0 million for FY2025, which is 3339.13% up from last year.
  • According to the latest figures from Q4 2025, Phibro Animal Health's Receivables is $215.9 million, which was up 1255.7% from $217.9 million recorded in Q3 2025.
  • Phibro Animal Health's Receivables' 5-year high stood at $228.0 million during Q2 2025, with a 5-year trough of $135.6 million in Q1 2021.
  • Moreover, its 5-year median value for Receivables was $158.7 million (2022), whereas its average is $167.6 million.
  • In the last 5 years, Phibro Animal Health's Receivables tumbled by 1055.32% in 2021 and then surged by 3552.68% in 2025.
  • Phibro Animal Health's Receivables (Quarter) stood at $142.5 million in 2021, then increased by 6.55% to $151.8 million in 2022, then fell by 0.79% to $150.6 million in 2023, then increased by 27.33% to $191.8 million in 2024, then grew by 12.56% to $215.9 million in 2025.
  • Its last three reported values are $215.9 million in Q4 2025, $217.9 million for Q3 2025, and $228.0 million during Q2 2025.